INTRODUCTION
The range of bioactive substances emerging as potential drug candidates, together with those currently under research and development, continue to provide major challenges for efficient drug delivery and targeting. Various strategies for formulation design using diverse chemicals as formulation excipients are available, and numerous materials are being considered and developed to provide specific fbnctionalities in the design of medicines. A number of approaches to formulation and drug delivery will be discussed at this symposium and this lecture, serving as a general introduction, highlights the need and value of these approaches coupled with the related issues of excipient properties and design.
It has been a constant ambition of formulation scientists to optimise drug delivery systems which provide a defined dose, at a chosen rate, at a selected time, to a targeted biological site. Whilst improvements in drug delivery over recent years are impressive, there is still some way to go in filly achieving these objectives. Key issues requiring continuing research and study range from fbndamental understanding of the biosystems and targets and basic characterisation of novel classes of bioactive agents, to the development of 'designer' or 'smart' materials which provide required excipient or carrier properties to achieve modulated and targeted drug delivery. Coupled with these activities is the necessary realism of the practical constraints imposed in designing drug delivery systems. These include the necessity of using materials which will achieve regulatory approval and clearance, and the constraints imposed by the nature of the various routes of administration available for drug delivery.
ROUTES OF ADMINISTRATION AND CLASSIFICATION OF DRUG DELIVERY SYSTEMS
The principal routes of administration for medicinal products are listed in Table 1 , together with a general classification of the main groups of traditional dosage forms. The choice of an appropriate route of administration for a specific bioactive will be influenced by many factors, such as required time of onset of action or drug targeting issues. Similarly, selection of drug delivery class is based on these and other numerous factors, as well as features related to the properties of the bioactive material itself, such as solubility and stability. 
EMULSIONS
The explosion of synthetic and semi-synthetic bioactive substances in the 1950's and 1960's, which continues to the present day, led to the development of a range of the conventional dosage forms which dominate the range of medicines available today. However, newer trends and strategies in drug discovery with the advent of highly potent compounds or those requiring location at specific biological tissues or sites has led to the development of alternative drug delivery systems, which attempt to address the requirements of rate and extent of drug release, and thereby absorption. Delivery systems include oral sustained release formulations' (e.g. multiple unit disintegrating particles or beads, single unit non-disintegrating system), controlled release preparations (e.g. oral osmotic pump2) and bioadhesives3 and liposomes4. The products of biotechnology research in the 1980's and 1990's have imposed even greater demands on drug delivery formulations and drug targeting with the emergence of peptides, problems, oligonucleotides and elements of DNA as potential drug candidates, since specific challenging features of such bioactives in terms of efficient and safe drug delivery need to be addressed from the points of view of administration route and suitable excipient and carrier materials. Table 2 highlights the various groups of chemicals that are used as vehicles, carriers and excipients in both conventional and more recent approaches to formulating medicines. Much research activity is focused on the development and testing of new carrier systems, such as biodegradable polymers, such as the polylactides, and composite materials like low density lipoproteins.
DRUG DELIVERY AND TARGETING
A diagramatic illustration of the inter-relationship between the components controlling the processes of drug delivery and targeting is presented in Figure 1 . In the diagram, the -microparticulate drug carrier system drug is delivered via a carrier system and four situations are identified. In A, leakage of the drug occurs as the drug-carrier system moves down the route of administration, whilst in B the drug is lost via the walls of the delivery route to non-target sites. In C and D, successfbl drug delivery to the target sites is achieved although drug loss to surrounding tissues can occur. Carefbl attention must thus be given to the characteristics of the targets, including access and location, as well as the characteristics of any carrier materials incorporated into drug delivery systems. 
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CARRIER SYSTEMS
In many cases, carrier materials are used in particulate forms, and Table 3 lists various types of microparticle colloidal carrier systems, together with ranges of particle diameters in nanometers. Microspheres and nanoparticles have continuous matrices containing dispersed or dissolved drug whilst microcapsules and nanocapsules are composed of a drug core surrounded by a layer acting as a coating or barrier to drug difision or dissolution. Vesicles are made up of single or multi-lamellar bilayer spherical particles containing drug within their lipid or aqueous regions. Emulsion and microemulsions are composed of oil or aqueous droplets dispersed in a continuous phase of the other liquid, or multiple emulsions (ie, oil-in-water-in-oil and water-in-oilin-water5), with drug dissolved in either or both oil and aqueous phases. Low-density lipoproteins have the benefit of being natural materials and drug can, for example, be adsorbed onto the protein or phospholipid head groups, solubilised in the lipid containing core, or attached to the surface. The range in particle sizes available for the various carrier systems provides potential regarding choice of administration route allowing smaller particles to be administered by parenteral routes for intravenous, subcutaneous and intramuscular drug delivery.
The types of carrier materials used, the drug substance and the biological environment for drug delivery all influence the mechanisms of drug release. Table 4 highlights the principal release mechanisms and drug, particle and environmental factors influencing drug release. The complex matrix of variables and interactions which influence and ultimately control drug release will clearly continue to provide major challenges for pharmaceutical scientists working in drug delivery and targeting. 
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AND DRUG TARGETING
A variety of approaches to formulation design are available and are being developed, some of which incorporate the newer excipients and materials with specific and directed fbnctionality in terms of drug release. Tables 5A and 5B list a number of formulation systems used by the oral, parenteral and pulmonary routes. Strategies range fiom chemical modification of the drug substance to provide a lower solubility salt, to more complex drug delivery systems involving enzymatic breakdown of a formulation component or particle coating to effect drug release', to the delivery of drugs containing liposomes to the lungs by nebulisation'.
Recent developments have hrther extended opportunities with the advent of externally activated drug delivery systems (see Table 6 ). Activating sources based on heat, sound, light, electrical pulses and magnetic fields are coupled with advanced materials incorporated into dosage forms to achieve controlled, pulsed and/or modulated drug release. Whilst many of these systems are in their infancy the potential of these approaches will continue to be explored, undoubtedly leading to advanced drug delivery systems. 6 DRUG PARTICLE ENGINEERING Drug particle engineering, or crystal engineering, provides an additional dimension to drug delivery and targeting. Traditional methods of particle formation, crystallisation and precipitation from solvents, do not generally provide the preferred properties required for formulation and processing of drugs into drug delivery systems, and it is common for additional processing to be carried out, such as milling and classification. However whilst such extra processing provides desired characteristics (eg, particle size and size distributions), changes in other properties can take place in an uncontrolled manner leading to batch inconsistency and thereby lack of precise control of performance in formulated products.' Physicochemical changes observed include solid state phase transitions and surface crystallisation. In this respect the non-equivalency of particles resulting from conventional crystallisation, harvesting and drying operation can be added to by fbrther processing. Understanding of these changes has been facilitated by recent developments in high resolution analytical techniques, such as microcalorimetry" inverse phase gas chromatography" and x-ray powder diffraction'*. The concept of optimising particulate formulations in terms of surface properties, such as surface energy requirements for powder inhalation drug delivery systems, is becoming a practical reality. The attractive alternative approach of producing drug particles and crystals with desired properties, such as particle size, shape, surface-free energy and crystallinity has been realised through the use of super-critical fluid te~hnology'~. In the SEDS process (Solution Enhanced Dispersion by Supercritical Fluids), two streams with one composed of a liquid solution containing the drug and a second containing supercritical carbon dioxide are introduced simultaneously using a coaxial nozzle arrangement into a particle formation vessel held at constant temperature and pressure supercritical conditions. The process involves virtually instantaneous dispersion, mixing and extraction of the solution solvent by the supercritical fluid leading to very high supersaturation ratios. These factors, together with precise control of relative flow rates of the two streams in the nozzle, provide uniform conditions for nucleation and particle formation, and the pure, solvent-free product is retained in the particle formation vessel. By varying the working conditions and changing the drug solution solvent, it has been shown possible to provide directed control over particle size, shape morphology, purity and polymorphic form. This capacity provides benefits over other reported techniques for particle formation using supercritical and clearly such precise manipulation of critically important properties of drug and carrier particles, coupled to consistency within and between batch, provides vast opportunities for drug delivery and targeted systems.
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CONCLUDING REMARKS
Whilst conventional dosage forms, such as tablets and hard gelatin capsules, composed of drugs with traditional excipients, continue today as the vast majority of formulations available for drug administration, major progress has been achieved over recent years in the fields of controlled drug delivery and targeting. Success in these areas is important both to improve the bioperfiormance and efficiency of drug delivery systems and to deal with recent trends in drug discovery. The range of materials used as hnctional excipients and carriers continues to grow, as does the novelty of alternative approaches in drug targeting. Nevertheless, the therapeutic agents emerging from studies in biotechnology, such as proteins and gene constructs, demand fbrther research and creativity due to their particular properties and targeting requirements. All these developments need to be paralleled by research and inventiveness in pharmaceutical material science and control of particles during their formation. Recent advances in applying supercritical fluid technologies do, however, provide opportunities for future developments in these areas.
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